The latest healthcare and wellness news from Asia and the Pacific

Provided by AGP

Got News to Share?

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on March 23, 2026

Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd
Inspire and HPV Cancers Alliance Launch New Online Community for People Affected by HPV-Related Cancers
NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™
MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer
Pontosense & Hokkai Choseikai Launch Privacy-Preserving Sensing Project in Kitahiroshima City
Intrinseque Health Receives Award for Best Clinical Development Supply Chain Solutions Partner 2026
NÖK Therapeutics to Present Long-Term Clinical Data at the 11th Annual Innate Killer Summit
NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session
Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026
Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors
On National Viagra Day, Women Finally Claim Their Turn:
MIMEDX Announces Launch of CHORIOFIX™
Sapu Nano to Present Everolimus Toxicology Data at SOT 2026 Annual Meeting
ORYZON Announces U.S. Patent Grant Covering Iadademstat Combinations with Venetoclax
Theriva™ Biologics Announces Positive End-of-Phase 2 Meeting with U.S. FDA Regarding the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma
Tempest Therapeutics Announces Up To $6 Million Private Placement
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering
Quality Longevity Company Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions
Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results

Share us

on your social networks:

Sign up for:

Asia Healthcare Industry Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.